Abbott Laboratories
Pharmaceutical or Nutritional Combination Comprising Beta-Hydroxy-Betamethylbutyrate

Last updated:

Abstract:

The present invention relates to a pharmaceutical or nutritional combination comprising beta-hydroxy beta-methylbutyrate (HMB) and tetrahydrocurcumin (THC) and methods comprising administering the combination to a subject. The methods of the invention relate to attenuating muscle protein degradation and/or preserving lean body mass in the subject.

Status:
Application
Type:

Utility

Filling date:

16 Jan 2017

Issue date:

22 Jul 2021